|
8 March 2023 |
("AMS", the "Company" or the "Group")
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies , makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:
|
Name of applicant: |
Advanced Medical Solutions Group plc |
|||
|
Name of scheme: |
Block Scheme for: 1. Deferred Share Bonus Scheme 2. Enterprise Management Incentive Scheme 3. Company Share Option Plan 4. Unapproved Executive Share Option Scheme 5. Long Term Incentive Plan 6. Deferred Annual Bonus Scheme |
|||
|
Period of return: |
From: |
6 September 2022 |
To: |
5 March 2023 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1. 186,786 2. Nil 3. 214,337 4. 671,754 5. 278,220 6. 248,616 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
1. Nil 2. Nil 3. Nil 4. Nil 5. Nil 6. Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
1. 34,107 2. Nil 3. 32,084 4. 84,802 5. 4,113 6. 2,275 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1. 152,679 2. Nil 3. 182,253 4. 586,952 5. 274,107 6. 246,341 |
|||
|
Number and class of securities originally listed and the date of admission: |
4,476,264 ordinary shares of 5p each on 6 September 2018 |
|||
|
Name of contact: |
Eddie Johnson |
|
Telephone number of contact: |
01606 545506 |
For further information, please visit www.admedsol.com or contact:
|
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
|
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer Michael King, Investor Relations |
|
|
Consilium Strategic Communications |
Tel: +44 (0) 20 3709 5700 |
|
Matthew Neal / Lucy Featherstone |
|
|
Investec Bank PLC (NOMAD & Broker) |
Tel: +44 (0) 20 7597 5970 |
|
Gary Clarence / David Anderson |
|
|
HSBC Bank plc (Broker) |
Tel: +44 (0) 20 7991 8888 |
|
Sam McLennan / Joe Weaving / Stephanie Cornish |